primidone Side Effects
Also known as: Mysoline
Analysis of 9,782 adverse event reports submitted to the FDA from 2002 to 2025.
Total Reports
9,782
Death-Related
850
8.7% of reports
Hospitalizations
3,062
31.3% of reports
Top Indication
Product Used For Unknown Indication
Most Reported Adverse Reactions
Who Reports Side Effects
Gender Distribution
Age Distribution
Reporting Trend by Year
Reactions in Death Reports
Top reactions reported in 850 reports where death was an outcome. These are voluntarily reported and do not establish causation.
| Reaction | Reports |
|---|---|
| DEATH | 289 |
| COMPLETED SUICIDE | 162 |
| TOXICITY TO VARIOUS AGENTS | 60 |
| CARDIAC ARREST | 35 |
| PNEUMONIA | 35 |
| RENAL FAILURE | 33 |
| FALL | 30 |
| DYSPNOEA | 29 |
| CARDIO-RESPIRATORY ARREST | 28 |
| ASTHENIA | 24 |
| FATIGUE | 24 |
| RESPIRATORY ARREST | 24 |
| ANAEMIA | 23 |
| CARDIAC FAILURE CONGESTIVE | 22 |
| HEPATIC FAILURE | 22 |
| RESPIRATORY FAILURE | 22 |
| CONDITION AGGRAVATED | 20 |
| DECREASED APPETITE | 20 |
| DIARRHOEA | 20 |
| HYPERTENSION | 20 |
Reactions in Hospitalization Reports
Top reactions in 3,062 reports where hospitalization was an outcome.
| Reaction | Reports |
|---|---|
| FALL | 376 |
| PNEUMONIA | 249 |
| TREMOR | 191 |
| DIARRHOEA | 186 |
| ASTHENIA | 173 |
| DYSPNOEA | 171 |
| NAUSEA | 169 |
| DRUG INEFFECTIVE | 166 |
| DRUG INTERACTION | 166 |
| FATIGUE | 157 |
| WEIGHT DECREASED | 147 |
| DIZZINESS | 146 |
| URINARY TRACT INFECTION | 138 |
| PAIN | 127 |
| VOMITING | 126 |
| PYREXIA | 118 |
| GAIT DISTURBANCE | 111 |
| HEADACHE | 110 |
| OFF LABEL USE | 103 |
| SOMNOLENCE | 102 |
Nearby — Related Medications
What the FAERS Data Reveals About primidone Side Effects
The FDA Adverse Event Reporting System (FAERS) contains 9,782 voluntary reports linked to primidone and its brand equivalents (Mysoline), spanning 2002 through 2025. Of those, 850 (8.7%) listed death as an outcome and 3,062 (31.3%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.
Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 60% were female and 40% male; age distribution skews toward 45-64, with 1,922 reports in that bracket. The single most reported reaction is drug ineffective with 813 submissions, followed by fall and fatigue.
FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice — speak with a licensed clinician about any side-effect concerns.
Read our methodology — how this data is sourced, computed, and verified.